4579:RaQualia Pharma Inc 
IPO Summary


 Index

Checking point of information
at the time of initial public offering.

 AI Analysis

■AI Analysis

 AI statistically analyzes IPO information to identify trends.
 The closer the number is to 5, the higher the rate of increase in the initial price relative to the offering price.
popularityscale-criteriaoffering-criteriaexchange-criteriamarket-conditionBusiness-criteria
124451
*This is an analysis of trends and does not guarantee any results.
This is not a solicitation to buy or sell stocks, nor is it investment advice.
*Please check the disclaimer for details.

■AI Analysis Chart

A group of stocks listed in the past
with similar IPO condition trends

NameRate of change
(Inicial Price)
8715: ANICOM HOLDINGS INC
+100.0%
6254: Nomura Micro Science Co Ltd
+63.9%
4242: TAKAGI SEIKO CORPORATION
+3.2%
4952: SDS Biotech
-7.6%
2183: Linical Co Ltd
-39.0%
7776: CellSeed Inc
-6.7%

 CompanyOverview

http://www.raqualia.co.jp/
4579:ラクオリア創薬 企業ホームページ

Initial Public Offering Memo

■ Market Cap | Offering rate | Dilution rate | lock-up information

■ Book building schedule | Payment schedule

  *1:(Period for applying lottery to obtain the right to purchase)
  *2:(The date when the purchase price is determined)
  *3:(Period for expressing your intent to purchase and payment,if you are selected in the lottery)

■ Detail of new issue or public offering

大和キャピタル・マーケッツ
Lead Sub

■ New issue or public offering - condition history

Update
date
Assumed issue
price
(JPY)
Tentatively
price range
(JPY)
Public offering
price
(JPY)
Priced 2011-07-081600 JPY1550 - 1600 JPY1600 JPY

Update
date
New issues
total shares
New issues
(Overseas)
PO&OA
total shares
PO
(Domestic)
PO
(Overseas)
OA
(Domestic)
OA
(Overseas)
Priced 2011-07-084,000,0000600,00000600,0000

※:( ) indicates the breakdown.
e.g. In the case of a PO(overseas), there are domestic and overseas allotments of the public offering, of which the overseas allotment is indicated.
PO : Public offering OA : Over allotment